Phase 2 Study of Neoadjuvant Treatment of Sequential S-1-Based Concurrent Chemoradiation Therapy Followed by Systemic Chemotherapy with Gemcitabine for Borderline Resectable Pancreatic Adenocarcinoma (HOPS-BR 01)Tsuyoshi Hayashi, Satoshi Hirano, Makoto Yoshida et al.|International Journal of Radiation Oncology*Biology*Physics|2019Cited by 26
HOPS-R01 phase II trial evaluating neoadjuvant S-1 therapy for resectable pancreatic adenocarcinomaMasahiro Shitani, Tsuyoshi Hayashi, Yasutoshi Kimura et al.|Scientific Reports|2022Cited by 3